Optimization of initial nanobiotechnology procedures to design a gold nanoparticle-based nucleic acid lateral flow assay to detect BRAF V600E mutation in papillary thyroid carcinoma

dc.contributor.authorWijesuriya, N.D.
dc.contributor.authorSiribaddana, P.
dc.contributor.authorJayathilaka, L.D.
dc.contributor.authorPriyani, A.A.H.
dc.contributor.authorJayasundara, D.R.
dc.contributor.authorThoradeniya, S.T.
dc.contributor.authorWijesundera, W.S.S.
dc.date.accessioned2026-08-25T04:13:06Z
dc.date.issued2022
dc.description.abstractIntroduction: Lateral flow assays (LFAs) have significant applications in point-of-care detection of cancer biomarkers. Proper validation of each step in their development process is crucial in achieving the final outcome. This study aimed to develop optimised protocols to design a gold nanoparticle (AuNP)-based nucleic acid lateral flow assay (NALFA) to detect the BRAF V600E mutation for prognostication of papillary thyroid carcinoma (PTC). Methods: Design of primers for the multiplex polymerase chain reaction (PCR) and oligonucleotide probes for LFA and optimization of multiplex PCR to amplify fragments of BRAF and GAPDH were carried out. Characterization of AuNPs, evaluation of their stability over time and assessment of their conjugation to detection probes (DPs) were performed.
dc.identifier.citationWijesuriya, N. D., Wijesundera, W. S. S., Thoradeniya, S. T., Jayasundara, D. R., Priyani, A. A. H., Jayathilaka, L. D., & Siribaddana, P. (2022). Optimization of initial nanobiotechnology procedures to design a gold nanoparticle-based nucleic acid lateral flow assay to detect BRAF V600E mutation in papillary thyroid carcinoma. Proceedings of the Annual Research Symposium-2022, University of Colombo, Sri Lanka, p. 199.
dc.identifier.urihttps://archive.cmb.ac.lk/handle/70130/9084
dc.language.isoen
dc.publisherUniversity of Colombo
dc.subjectBRAF V600E
dc.subjectgold nanoparticle-based nucleic acid lateral flow assay
dc.subjectmultiplex polymerase chain reaction
dc.subjectpapillary thyroid carcinoma
dc.titleOptimization of initial nanobiotechnology procedures to design a gold nanoparticle-based nucleic acid lateral flow assay to detect BRAF V600E mutation in papillary thyroid carcinoma
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
20.pdf
Size:
251.7 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: